News & Events
-
November 4, 2017
Allowing Respondents to Skip Items During Electronic Collection of Patient-Reported Outcome (PRO) Data: Does It Matter?
O’Donohoe P, Eremenco S, Coons SJ, Crescioni M, Arnera V. Allowing Respondents to Skip Items During Electronic Collection of Patient-Reported Outcome (PRO) Data: Does It Matter? International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress; 2017 Nov 4; Glasgow, Scotland.
-
November 1, 2017
FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMRI) as a prognostic biomarker for pre-dementia clinical trials for Alzheimer disease therapeutics
Conrado, D.J., et al.; “FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMRI) as a prognostic biomarker for pre-dementia clinical trials for Alzheimer disease therapeutics.” 10th Clinical Trials on Alzheimer’s Disease (CTAD), Boston, MA, November 1-4, 2017, The Journal of Prevention of Alzheimer’s Disease 4(4): 345. -
November 1, 2017
Informed consent ensuring access to anonymized patient-level data and biospecimen is critical to accelerating innovative Alzheimer disease treatments
Arnerić, S.P., et al.; “Informed consent ensuring access to anonymized patient-level data and biospecimen is critical to accelerating innovative Alzheimer disease treatments.” 10th Clinical Trials on Alzheimer’s Disease (CTAD), Boston, MA, November 1-4, 2017, The Journal of Prevention of Alzheimer’s Disease 4(4): 387. - October 31, 2017
-
October 26, 2017
226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
Aartsma-Rus A, Ferlini A, McNally EM, Spitali P, Sweeney HL, Aartsma-Rus AM, Szigyarto CAK, Bello L, Bronson A, Brown K, Buccella F, Chadwick J, Ferlini A, Frank D, Hoffman E, Larkindale J, McClorey G, McNally E, Munschauer R, Muntoni F, Owens J, Schara U, Spitali P, Straub V, Sweeney L, Tinsley J, Versnel J, Vroom E, Welch E. 226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy. Neuromuscular Disorders. 2017 Oct.